FIELD: medicine.
SUBSTANCE: offered methods of neural disorder treatment include introduction of agent containing combination of dextromethorphane and quinidine.
EFFECT: allow for considerably higher system availability of dextromethorphane.
24 cl, 7 dwg, 57 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEXTROMETHORPHAN TRANSDERMAL DELIVERY DEVICE | 2018 |
|
RU2795729C2 |
| NEW COMBINATIONS OF NERAMEXANE FOR TREATING NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2432161C1 |
| USE OF DEXTROMETHORPHAN AND OXIDASE INHIBITOR FOR REMOVING ADDICTION TO NARCOTICS AND ANTIDEPRESSANTS IN PATIENTS | 2000 |
|
RU2281771C2 |
| NERAMEXANE TITRATION KIT AND USING IT IN TREATING INTERNAL EAR DISORDERS | 2008 |
|
RU2459618C2 |
| COMPOSITIONS AND METHODS ASSOCIATED THEREWITH | 2017 |
|
RU2764716C2 |
| METHODS FOR TREATMENT OF GAUCHER DISEASE | 2018 |
|
RU2781242C2 |
| 1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING COCHLEAR TINNITUS | 2008 |
|
RU2438658C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION | 2011 |
|
RU2571284C2 |
| TARGET DRUG WITH NEW COMPOSITIONS, COMBINATIONS AND METHODS | 2018 |
|
RU2760558C2 |
| ANALGETIC COMPOSITIONS CONTAINING NON-NARCOTIC ANALGETIC AND ENHANCER OF ANALGESIA | 1995 |
|
RU2213561C2 |
